MYO10 promotes tumor progression by inducing genomic instability, which, in turn, creates an immunogenic environment for immune checkpoint blockades; when upregulated in both human and mouse tumors, its expression level predisposes tumor progression [22]. The gene discussed is MYO10; the disease is neoplasm.